CDC experts back Pfizer shot in adolescents To view this email as a web page,
click here Emergent BioSolutions CEO, founder head for the Hill as Congress probes production contracts, errors As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal COVID-19 tracker: CDC advisers endorse Pfizer shot for adolescents; Emergent leadership called before Congress CMS requires nursing homes to report COVID-19 vaccination rates Trials ramping back up, but slow takeup of places remain a barrier: report Hospital groups press HHS to give out rest of relief funds, extend key deadline Featured Story | By Fraiser Kansteiner Emergent BioSolutions' top brass is headed to the Hill as part of an ongoing congressional probe into the company. The manufacturer has been in the crosshairs ever since a production snafu at its Baltimore, Maryland, plant ruined up to 15 million Johnson & Johnson COVID-19 vaccine doses. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor The U.K. government has rethought plans to buy one million doses of an anti-SARS-CoV-2 antibody in development at AstraZeneca, according to anonymous sources quoted by Bloomberg. News of the rethink comes shortly before AstraZeneca is due to deliver late-phase data on the candidate. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner A CDC committee of vaccine experts endorsed the use of Pfizer's BioNTech-partnered vaccine in adolescents. Emergent's top executives have been called to testify before lawmakers over manufacturing contracts and production errors. CDC confirms more cases of rare blood clots among J&J recipients. And more headlines. read more By Robert King CMS issued a final rule requiring nursing homes to report COVID-19 vaccination data to help determine if some facilities need more help. read more By Ben Adams As the pandemic is being beaten back in the U.S. and U.K. (but is still rampant in other areas of the globe), clinical trials are able to get back on track, but slow enrollment is still an issue. read more By Robert King Major hospital groups are asking the Department of Health and Human Services to extend a June 30 deadline for providers to use up COVID-19 relief funds and distribute the remaining funding. read more |
|
